Could 31, 2024 – B. Braun Medical Inc. introduced the launch of its new product line Levetiracetam in Sodium Chloride Injection. This new product providing expands the corporate's anticonvulsant portfolio to incorporate Levetiracetam in three concentrations. Levetiracetam in Sodium Chloride Injection, manufactured by B. Braun in Irvine, CA, is on the market in our versatile PAB® IV containers in strengths 500 mg/100 ml, 1,000 mg/100 ml and 1,500 mg/100 ml.
Making the PAB IV containers in Irvine helps guarantee B. Braun's supply reliability. This Levetiracetam product providing consists of options similar to stackable, biodegradable particular person unit liners, distinctive colours for dosage differentiation and an 18-month shelf life. As well as, the inside bins match compactly across the containers to reduce wasted house.
Levetiracetam in sodium chloride injection is indicated as adjunctive remedy in adults 16 years of age or older with the next kinds of seizures, when oral administration is quickly not possible:
- Partial incipient seizures
- Myoclonic seizures in sufferers with juvenile myoclonic epilepsy
- Major generalized tonic-clonic seizures
Be taught extra